Atlas Trials

The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer

Clinical trial NCT06623487 · RECRUITING

Trial details

NCT number
NCT06623487
Sponsor
Ruijin Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Carcinoma, Non-Small-Cell LungPET / CTNeoadjuvant Immunotherapy
Start date
2024-07-19
Primary completion
2026-06-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.